Products Liability and Pharmacy Lien: A Case Study in Defective Equipment Injury

James Wong — Founder & Pharmacist, LienScripts | December 12, 2025 | 9 min read

When a defective product causes a serious injury, the resulting PI claim can involve complex medication management over months or years. This case study illustrates how a pharmacy lien program supports a products liability case from injury through settlement.

Case Background

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

The Client: Marcus D., 34, a warehouse fulfillment worker in the Dallas-Fort Worth metro area.

The Incident: Marcus was operating a commercial pallet jack that had been manufactured with a known hydraulic defect — a faulty pressure valve that could fail under standard load conditions. During a routine stacking operation, the hydraulic system failed without warning, dropping a 1,200-pound load of boxed merchandise onto the left side of Marcus's body.

Injuries Sustained:

• Left tibial plateau fracture (requiring surgical fixation)
• Left femoral shaft fracture (intramedullary nail fixation)
• L2-L3 disc herniation with left-sided radiculopathy
• Peroneal nerve injury with foot drop
• Soft tissue crush injuries to the left lower extremity
• Acute stress reaction with subsequent PTSD symptomatology

The Legal Context:

Marcus's employer was the party operating the warehouse. The pallet jack was manufactured by a third party — a commercial equipment manufacturer. The defect had been reported in prior incidents, and an internal engineering report (later produced in discovery) documented the pressure valve issue without triggering a recall.

Marcus's workers' compensation carrier covered his initial hospitalization and early surgical care. However, workers' comp pharmacy benefits were limited under the Texas workers' comp formulary — several of Marcus's post-discharge medications were denied as non-formulary, and workers' comp benefits ended at maximum medical improvement (MMI), leaving ongoing chronic pain management uncovered.

His attorney filed a third-party products liability lawsuit against the manufacturer. LienScripts was enrolled for pharmacy services at the attorney's referral, beginning at the time workers' comp pharmacy benefits started declining coverage.

[!KEY] Products liability cases often involve more severe injuries than standard auto accident cases — and therefore more complex, long-duration medication regimens. A pharmacy lien program that documents the full medication history from the point workers' comp coverage ends is essential for capturing the complete pharmaceutical economic damages in the demand against the manufacturer.

The Medication Timeline

Weeks 1–4 (Acute Hospitalization): Workers' comp covered the initial hospitalization, surgical procedures, and in-hospital medications including:

• IV opioid analgesics (post-surgical pain management)
• Pre-operative antibiotics
• Deep vein thrombosis prophylaxis (enoxaparin)

These prescriptions were billed through workers' comp and are part of the workers' comp record, not the pharmacy lien. They establish the severity and surgical complexity of the initial injury.

Months 1–3 (Post-Discharge, Workers' Comp Active): Marcus was discharged to outpatient care. Workers' comp covered some medications, but denied others as non-formulary for the Texas workers' comp system:

• Oxycodone IR (covered, workers' comp) — acute post-op pain
• Gabapentin 1800 mg/day (initially denied as non-formulary, later approved after appeal)
• Topical diclofenac gel (denied as non-formulary → enrolled in pharmacy lien)
• Baclofen for spasticity from peroneal nerve damage (denied → enrolled in pharmacy lien)

LienScripts enrollment began at month 2, covering the denied medications.

Months 3–14 (Workers' Comp MMI → Third-Party Litigation Active): Workers' comp declared MMI at month 8. At that point, ALL pharmacy benefits under workers' comp ended. Marcus's medication needs at that point included:

• Gabapentin 2400 mg/day (nerve pain from peroneal injury and radiculopathy)
• Meloxicam 15 mg (lumbar inflammation)
• Baclofen 20 mg/day (spasticity management)
• Duloxetine 60 mg (chronic pain + depression)
• Sertraline 100 mg (PTSD)
• Prazosin 2 mg at bedtime (PTSD nightmares)
• Zolpidem 10 mg (sleep maintenance)
• Omeprazole 20 mg (gastroprotection with long-term NSAID use)

All eight medications from month 8 through settlement were covered under the pharmacy lien program.

Month 14: Case settled against the manufacturer.

The Pharmacy Record's Role in the Demand

The products liability demand against the manufacturer needed to establish:

1. Causation: The defective pallet jack caused the injuries
2. Injury severity: The injuries were serious, permanent, and required extensive ongoing medical management
3. Economic damages: The medical costs, lost wages, and future care costs were substantial
4. Non-economic damages: The physical pain, emotional trauma, and life impact were severe

The pharmacy lien record contributed to every element:

To causation: The prescription timeline corroborated the medical record — gabapentin starting at 6 weeks post-injury, duloxetine introduced at month 5 when depression was formally documented, prazosin at month 7 when PTSD nightmares became a clinical focus. Each medication's introduction date was consistent with the expected clinical progression of the injury.

To injury severity: Six months of gabapentin at escalating doses, eight months of duloxetine, a year of sleep medications — these are not the prescriptions of a patient who had a minor injury.

[!KEY] When workers' comp declares MMI and ends pharmacy benefits, a pharmacy lien activated on the same day creates a seamless handoff with no gap — the gap between MMI and settlement can span months, and every uncovered prescription during that period is a treatment gap the manufacturer's defense will exploit. The duration and complexity of the regimen demonstrated the chronic, multi-system nature of the injury.

To economic damages: The MERIT report itemized 14 months of pharmacy lien fills — eight medication lines across the post-MMI period — producing a documented pharmacy lien total that became a line item in the medical expense section of the demand.

To non-economic damages: Prazosin and sertraline together document PTSD. Zolpidem and trazodone together document chronic sleep disruption. Duloxetine documents chronic pain-related depression. Each medication tells a piece of the story of daily life with these injuries.

Defense Challenges and Responses

"The workers' comp record already captures the injury — we shouldn't be liable for additional damages."

Response: Workers' comp is a separate system that pays fixed benefits regardless of fault. The third-party products liability claim compensates Marcus for the full extent of his damages — including the medications that workers' comp denied, the ongoing costs after MMI, and the pain and suffering that workers' comp doesn't compensate.

"The gabapentin and psychiatric medications are pre-existing."

Response: The pharmacy record showed no gabapentin, antidepressants, or sleep medications in the workers' comp record before the injury. The first prescriptions for every PTSD and neuropathic pain medication appeared after the injury date — establishing the temporal relationship between the defective equipment failure and the medication profile.

[!KEY] In a products liability case, prazosin and sertraline together document PTSD, zolpidem documents chronic sleep disruption, and duloxetine documents chronic pain-related depression — each psychiatric medication independently corroborates the non-economic damages narrative that the defective equipment destroyed the plaintiff's quality of life.

"The plaintiff could have managed his pain with over-the-counter medications."

Response: The prescribing physician made a clinical judgment that prescription-strength medications were necessary. The workers' comp carrier's approval of some medications and the treating physicians' continued prescribing after workers' comp MMI both reflect independent clinical decisions that the medications were medically necessary.

Settlement and Lien Resolution

At settlement, the pharmacy lien was resolved proportionally from the proceeds attributable to medical expenses. The workers' comp carrier exercised its statutory subrogation rights against the third-party recovery for compensation it had paid — a separate calculation from the pharmacy lien. The pharmacy lien and workers' comp subrogation did not compete for the same dollars.

The MERIT report was provided to defense counsel during the settlement conference, where it supported the economic damages figure in the demand. The manufacturer's counsel acknowledged the documentation as organized and credible.

Related Resources

• Workers' Comp vs. Personal Injury Liens
• Product Liability and Pharmacy Liens
• What Is a MERIT Report?
• Construction Accident Injury and Pharmacy Liens
• Case Study: Workers' Comp Dual Claim